EI
BMY icon

Ellevest Inc’s Bristol-Myers Squibb BMY Stock Holding History

Ellevest Inc’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$498K Buy
8,540
+39
+0.5% +$2.24K 0.06% 255
2026
Q1 		$516K Sell
8,501
-486
-5% -$28.3K 0.07% 219
2025
Q4 		$485K Buy
8,987
+109
+1% +$5.24K 0.07% 235
2025
Q3 		$400K Buy
8,878
+3,772
+74% +$176K 0.06% 268
2025
Q2 		$236K Sell
5,106
-1,337
-21% -$65.6K 0.04% 345
2025
Q1 		$393K Sell
6,443
-3,951
-38% -$230K 0.03% 239
2024
Q4 		$588K Buy
10,394
+1,657
+19% +$92.6K 0.03% 172
2024
Q3 		$452K Sell
8,737
-143
-2% -$6.71K 0.03% 238
2024
Q2 		$369K Buy
8,880
+186
+2% +$8.32K 0.02% 280
2024
Q1 		$471K Buy
8,694
+86
+1% +$4.38K 0.03% 218
2023
Q4 		$442K Sell
8,608
-1,164
-12% -$61.1K 0.03% 211
2023
Q3 		$567K Sell
9,772
-304
-3% -$18.6K 0.04% 128
2023
Q2 		$644K Buy
10,076
+634
+7% +$42.5K 0.05% 110
2023
Q1 		$654K Sell
9,442
-3,332
-26% -$235K 0.05% 95
2022
Q4 		$919K Buy
12,774
+1,078
+9% +$81.3K 0.08% 67
2022
Q3 		$831K Buy
11,696
+492
+4% +$35.7K 0.08% 57
2022
Q2 		$863K Buy
11,204
+1,153
+11% +$87.8K 0.08% 59
2022
Q1 		$734K Buy
10,051
+2,570
+34% +$173K 0.06% 74
2021
Q4 		$466K Buy
7,481
+4,707
+170% +$276K 0.04% 117
2021
Q3 		$164K Buy
2,774
+170
+7% +$11.2K 0.02% 308
2021
Q2 		$174K Buy
2,604
+366
+16% +$23.9K 0.02% 285
2021
Q1 		$141K Sell
2,238
-178
-7% -$11.1K 0.02% 286
2020
Q4 		$150K Buy
2,416
+289
+14% +$17.8K 0.02% 224
2020
Q3 		$128K Buy
2,127
+80
+4% +$4.82K 0.02% 190
2020
Q2 		$120K Buy
2,047
+500
+32% +$29.9K 0.03% 169
2020
Q1 		$86K Sell
1,547
-30
-2% -$1.83K 0.02% 158
2019
Q4 		$101K Buy
1,577
+1,355
+610% +$77.6K 0.03% 108
2019
Q3 		$11K Sell
222
-914
-80% -$43K ﹤0.01% 221
2019
Q2 		$52K Buy
+1,136
New +$52.9K 0.02% 114

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ellevest Inc's BMY Position: Q2 2026 in Review

Ellevest Inc increased its Bristol-Myers Squibb (BMY) stake by 0.46% in Q2 2026, buying an estimated $2.24K and bringing the position to 8,540 shares worth $498K. The position accounts for 0.06% of the portfolio, ranked #255.

Ellevest Inc first reported a position in BMY in Q2 2019 and has held it in 29 quarters since. The position peaked at $919K in Q4 2022. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Ellevest Inc held 8,540 shares of Bristol-Myers Squibb worth $498K as of Q2 2026.
  • Ellevest Inc bought 39 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.24K.
  • Bristol-Myers Squibb made up 0.06% of Ellevest Inc's portfolio in Q2 2026, its #255 holding.
  • Ellevest Inc first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 29 quarters since.
  • Ellevest Inc's Bristol-Myers Squibb position peaked at $919K in Q4 2022.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Ellevest Inc's 13F filing for Q2 2026, filed 10 Aug 2026.